Rigel Pharmaceuticals
RIGL
#6719
Rank
NZ$0.82 B
Marketcap
$46.77
Share price
0.70%
Change (1 day)
243.91%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): -NZ$11.19 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2023 the company made an earning of -NZ$31.09 Million, an increase over its 2022 earnings that were of -NZ$93.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$11.19 Million-64.01%
2023 -NZ$31.09 Million-66.79%
2022 -NZ$93.62 Million340.73%
2021 -NZ$21.25 Million-56.15%
2020 -NZ$48.45 Million-57.34%
2019 -NZ$0.12 Billion-7.66%
2018 -NZ$0.13 Billion-9.47%
2017 -NZ$0.14 Billion24.46%
2016 -NZ$0.11 Billion23.63%
2015 -NZ$88.29 Million-43.29%
2014 -NZ$0.16 Billion2.5%
2013 -NZ$0.16 Billion
2010 NZ$64.59 M-133.97%
2009 -NZ$0.2 Billion-18.49%
2008 -NZ$0.24 Billion71.91%
2007 -NZ$0.14 Billion84.74%
2006 -NZ$73.45 Million-10.17%
2005 -NZ$81.77 Million-15.73%
2004 -NZ$97.03 Million39.29%
2003 -NZ$69.66 Million10.3%
2002 -NZ$63.16 Million48.3%
2001 -NZ$42.59 Million-2.13%
2000 -NZ$43.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.23 Billion 1,902.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.36 Billion 3,065.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.04 B-144,236.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$7.98 B-71,830.80%๐Ÿ‡บ๐Ÿ‡ธ USA